Pre-clinical metabolism studies with Fenretinide in paediatric cancer
Fenretinide (4-HPR) is a retinoic acid analogue used in clinical trials for the treatment of neuroblastoma and Ewing’s sarcoma. The work described involves investigations into factors that may impact on 4-HPR drug disposition. Metabolism of 4-HPR is of particular interest due to production of the ac...
| Main Author: | |
|---|---|
| Published: |
University of Newcastle Upon Tyne
2011
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.556036 |